ALK receives positive recommendation for EURneffy® 1 mg: A needle-free anaphylaxis treatment for children | ALK

ALK receives positive recommendation for EURneffy® 1 mg: A needle-free anaphylaxis treatment for children

Link

https://www.globenewswire.com/news-release/2026/01/29/3228809/0/en/ALK-receives…

Created date

Thu, 01/29/2026 - 12:00

Nasdaq ID

3228809

Last updated: 29.01.2026